Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

A society-wide conversation is needed about germline genome editing using CRISPR

Nature Medicine volume 30, pages 30–32 (2024)Cite this article

Subjects

Therapeutic genome editing has great potential to cure some rare diseases, but germline editing is banned. With a broad societal discussion supported by national and transnational legislation, it could be allowed in certain circumstances.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Doudna, J. A. & Charpentier, E. Science 346, 1258096 (2014).

    Article  PubMed  Google Scholar 

  2. Hsu, P. D. et al. Nat. Biotechnol. 31, 827–832 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Komor, A. C. et al. Nature 533, 420–424 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Anzalone, A. V. et al. Nature 576, 149–157 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Adli, M. Nat. Commun. 9, 1911 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Frangoul, H. et al. N. Engl. J. Med. 384, 252–260 (2021).

    Article  CAS  PubMed  Google Scholar 

  7. Kaiser, J. Science https://doi.org/10.1126/science.adf8752 (2022).

    Article  PubMed  Google Scholar 

  8. Musunuru, K. et al. Nature 593, 429–434 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Kolli, N. et al. Int. J. Mol. Sci. 18, 754 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nagata, K. et al. Nat. Commun. 9, 1800 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stadtmauer, E. A. et al. Science 367, eaba7365 (2020).

    Article  CAS  PubMed  Google Scholar 

  12. Hu, W. et al. Proc. Natl. Acad. Sci. USA 111, 11461–11466 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Harper, J. C. et al. Eur. J. Hum. Genet. 26, 12–33 (2018).

    Article  CAS  PubMed  Google Scholar 

  14. Callaway, E. Nature 530, 18–18 (2016).

    Article  CAS  PubMed  Google Scholar 

  15. Isasi, R., Kleiderman, E. & Knoppers, B. M. Science 351, 337–339 (2016).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

E.B. thanks V. Hatch for support in producing this Comment.

Author information

Authors and Affiliations

  1. European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridgeshire, UK

    Ewan Birney

Authors
  1. Ewan Birney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ewan Birney.

Ethics declarations

Competing interests

E.B. is a paid consultant to Oxford Nanopore and Cantana and a shareholder of Oxford Nanopore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Birney, E. A society-wide conversation is needed about germline genome editing using CRISPR. Nat Med 30, 30–32 (2024). https://doi.org/10.1038/s41591-023-02681-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02681-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing